ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,024, issued on May 12, was assigned to Reservoir Neuroscience Inc. (San Francisco).
"EP2 antagonist compounds" was invented by Matthew Alexander James Duncton (San Bruno, Calif.), Vladimir V. Senatorov Jr. (Oakland, Calif.), Aaron R. Friedman (Berkeley, Calif.) and Steven Howard Olson (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds of Formula (II):that are EP2 antagonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of diseases or conditions associated with EP2 activity."
The patent was filed on D...